Octreotide Acetate for Injection
Indication
Hemostatic drugs. Mainly used for bleeding caused by excessive primary fibrinolysis, including acute and chronic, localized or systemic hyperfibrinolytic bleeding, the latter of which is common in cancer, leukemia, gynecological accidents, severe liver disease bleeding, etc.
Packaging Specification
0.1mg
Manufacturer
Liaoning Nirvana Pharmaceutical Co., Ltd.
-
Founded in:
2008-11-05 -
Address:
No. 61 Xianghuai Road, Benxi Economic Development Zone -
Tax NO.:
912105006800780620 -
Registered Funds:
51.325 million yuan -
Website:
-
Email: